Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketanserin effects on peripheral temperature and lactate in critically ill ICU patients
NL-OMON46490Phase 4Active, not recruiting
- Sponsor
- OLVG
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketanserin in Cardiovascular collapse and Shock (2 arms), sponsored by OLVG. Primary endpoint: Change in DeltaT. Started Apr 2018; status: active, not recruiting.
02
Drugs
ketanserin
03
Conditions
Cardiovascular collapseShock
Beyond the preview
Go deeper on NL-OMON46490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46490.